Clinical Trials Logo

Filter by:
NCT ID: NCT00827723 Completed - Clinical trials for Carcinoma, Hepatocellular

Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma

Start date: February 2009
Phase:
Study type: Observational

The aim of the investigators' study is to elucidate the relationship between a functional liver test (e.g., ICG) and the PREOPERATIVE value of portal hypertension in the patients with impaired liver function from alcoholic and non-alcoholic aetiologies. Alcoholic and viral cirrhosis present important differences in terms of cellular mechanisms responsible for the disease progression with a distinct and unique gene expression pattern that regulates the type of inflammatory response. These differences probably influence the hepatic functional reserve and the onset of portal hypertension at a comparable clinical and biological level of derangement and the investigators may expect significant differences in the recovery from hepatectomy. The investigators' hypothesis is that at a comparable ICGR-15 rate non-viral cirrhotic liver presents higher portal pressure values and the investigators also argue that alcoholic cirrhotic patients would tolerate a larger hepatic resection than would viral cirrhotic do.

NCT ID: NCT00827606 Completed - Clinical trials for Familial Hypercholesterolemia

Atorvastatin Three Year Pediatric Study

Start date: March 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to characterize three year descriptive growth and development (ie, height, weight, body mass index, Tanner Stage) and efficacy of cholesterol reduction in pediatric subjects with Heterozygous Familial Hypercholesterolemia receiving atorvastatin treatment.

NCT ID: NCT00827450 Completed - Hepatic Steatosis Clinical Trials

Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet

COLIBRI
Start date: February 2009
Phase: N/A
Study type: Interventional

This study will assess - whether coffee consumption protects against fructose-induced hepatic steatosis in healthy humans - whether the protective effect of coffee is dependent on it's antioxidant composition

NCT ID: NCT00827216 Completed - Gastric Emptying Clinical Trials

The Effect of Intravenous Erythromycin on Gastric Emptying in Non-fasted Patients Before Emergency Total Anesthesia

Start date: January 2009
Phase: Phase 2
Study type: Interventional

In this study the investigators want to investigate the effect of a short intravenous infusion of Erythromycine on gastric emptying on patients considered "full stomac" and scheduled for Emergency operation. A gastroscopy will be done after intubation to controll the effect of the perfusion.

NCT ID: NCT00826969 Completed - Asthma Clinical Trials

Ciclesonide for the Treatment of Airway Hyperresponsiveness

Start date: September 2008
Phase: Phase 4
Study type: Interventional

The study objective is to investigate in a placebo-controlled, double-blind manner the effect of inhaled corticosteroid (ciclesonide) on airway hyperresponsiveness measured as having PD15 mannitol. Treatment medication will be administered as follows: 320 microgram ciclesonide or placebo will be inhaled once daily. The study duration consists of a treatment period of 4 weeks. The study will provide further data on safety of ciclesonide.

NCT ID: NCT00826670 Completed - Clinical trials for Enterobacteriaceae Infections

Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study

Start date: June 2009
Phase: Phase 4
Study type: Interventional

Multidrug-resistant Enterobacteriaceae producing extended-spectrum β-lactamases (hereafter called ESBLs) have emerged as an important cause of bloodstream infection in hospitalized patients and urinary tract infections in the community. As is the case with other multidrug-resistant organisms chronic colonization is frequent, in the case of ESBLs mostly intestinal and urinary carriage. To the investigators knowledge no randomized, placebo-controlled clinical trial has been performed to study the efficacy of a systematic ESBL eradication strategy. Eradication of ESBL carriage would cause benefits for the individual patient - by reducing the risk of infection - and for the community - by reducing transmission. Even if eradication turns out to be impossible, transient suppression of ESBL might reduce the likelihood of transmission and thus still be beneficial from an ecologic perspective. The purpose of the proposed study is to test the hypothesis that the administration of a 10 day course of oral antibiotics active against ESBLs can lead to decolonization of ESBL carriage in hospitalized patients.

NCT ID: NCT00826579 Completed - Colonic Neoplasms Clinical Trials

Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer

Start date: May 2000
Phase: Phase 1/Phase 2
Study type: Interventional

The study is a feasibility and validation study of the sentinel lymph node (SLN) procedure in all stages of colon cancer. If the SLN can be reliably identified, it could be submitted to a more accurate histopathological examination (multiple sections, special staining). The detection of micrometastases in the SLN (occult stage III, upstaging) is possible. Patients with micrometastases should be considered at higher risk. Additionally, a search for occult metastatic tumor cells in the bone marrow is performed.

NCT ID: NCT00826514 Completed - Clinical trials for Chronic Prostatitis With Chronic Pelvic Pain Syndrome

An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis

Start date: March 25, 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether tanezumab is effective in the treatment of pain associated with chronic prostatitis.

NCT ID: NCT00824980 Recruiting - Psoriasis Clinical Trials

Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis

Start date: January 2009
Phase: Phase 2
Study type: Interventional

The major objective of this study is to evaluate the therapeutic effect of a topical treatment simultaneously inhibiting Dipeptidyl Peptidase IV and Aminopeptidase N (IMTM #IP10.C8) in patients with mild to moderate psoriasis of the skin

NCT ID: NCT00824460 Completed - Clinical trials for Chronic Kidney Disease

Study of Phosphate Levels in Patients With Chronic Kidney Disease

PA21
Start date: December 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the ability of different doses of PA21 to lower serum phosphate levels, in patients with chronic kidney disease on maintenance hemodialysis.